BioCentury
ARTICLE | Clinical News

Ceprate SC stem cell concentration system that uses avidin-biotin binding to separate stem and progenitor cells in blood: Began Phase III trial in the U.S. and

January 23, 1995 8:00 AM UTC

CellPro Inc. (CPRO), Seattle Product: Ceprate SC stem cell concentration system that uses avidin-biotin binding to separate stem and progenitor cells in blood Indication: Advanced multiple myeloma aft...